1349 related articles for article (PubMed ID: 20421486)
1. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity.
Weinberg F; Hamanaka R; Wheaton WW; Weinberg S; Joseph J; Lopez M; Kalyanaraman B; Mutlu GM; Budinger GR; Chandel NS
Proc Natl Acad Sci U S A; 2010 May; 107(19):8788-93. PubMed ID: 20421486
[TBL] [Abstract][Full Text] [Related]
2. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing.
Song JH; An N; Chatterjee S; Kistner-Griffin E; Mahajan S; Mehrotra S; Kraft AS
Oncogene; 2015 Jul; 34(28):3728-36. PubMed ID: 25241892
[TBL] [Abstract][Full Text] [Related]
4. Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth.
Nagdas S; Kashatus JA; Nascimento A; Hussain SS; Trainor RE; Pollock SR; Adair SJ; Michaels AD; Sesaki H; Stelow EB; Bauer TW; Kashatus DF
Cell Rep; 2019 Aug; 28(7):1845-1859.e5. PubMed ID: 31412251
[TBL] [Abstract][Full Text] [Related]
5. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
[TBL] [Abstract][Full Text] [Related]
6. MTH1 expression is required for effective transformation by oncogenic HRAS.
Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
[TBL] [
